Important pharmacy news and late-breaking industry information updated daily.

The Trump administration's budget requests $87.1 billion for HHS, a 12% decline from the estimated 2019 level. The budget provides $291 million to address HIV/AIDS, with $140 million for CDC to reduce new HIV infections. It also includes a new user fee on electronic cigarettes.

Every year, the American Diabetes Association (ADA) releases updated guidelines for management of diabetes. “Standards of Medical Care in Diabetes–2019,” published in Diabetes Care, includes 16 sections, with a dedicated new section on diabetes technology. Numerous revisions were made throughout the updated guidelines, with key revisions focusing on updated diagnostic criteria, changes in pharmacological management of type 2 diabetes, and the importance of the integrated care team and patient preferences.

CDC reported Friday that influenza activity remains elevated throughout the United States, and some states are experiencing a second wave of severe infections.

New research reflects an expansion of opioid-related deaths from rural, low-income states to eastern states.

FDA Commissioner Scott Gottlieb, MD, announced Thursday that the agency no longer plans to change the proper names of biological products that have already been licensed or approved under the Public Health Service Act without an FDA-designated suffix in their proper names.

FDA approved on Tuesday esketamine (Spravato—Janssen Pharmaceuticals) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have treatment-resistant depression. Esketamine is the s-enantiomer of ketamine.

FDA issued final guidance for outsourcing facilities that make drugs using bulk substances. The guidance, Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act, outlines a framework FDA will use to determine when there is a clinical need for facilities to make drugs using bulk substances. FDA said the new measures are being set in place to protect patients.

A second patient has experienced long-term remission from HIV, according to new research. The findings, which come almost exactly 12 years after the first patient was reported to be cured, are set to be published Tuesday in Nature and presented at the Conference on Retroviruses and Opportunistic Infections in Seattle.

Aspiring Certified Pharmacy Technicians (CPhTs) can expect changes to certification beginning in 2020.

FDA released on Friday an update regarding the agency's ongoing investigation into the voluntary recalls of several angiotensin II receptor blocker (ARB) drug products used to treat high blood pressure and heart failure. According to the agency, Hetero Labs Ltd.